Pedro Lasanta - Pharma-Bio Serv CFO, VP of Fin. and Admin. and Secretary

PBSV Stock  USD 0.53  0.03  6.00%   

CFO

Mr. Pedro J. Lasanta is the Chief Financial Officer, Vice President Finance and Administration, Secretary of the company. From 2006 until October 2007, Mr. Lasanta was in private practice as an accountant, tax and business counselor. From 1999 until 2006, Mr. Lasanta was the Chief Financial Officer for Pearle Vision Center PR, Inc. In the past, Mr. Lasanta was also an audit manager for Ernst Young, formerly Arthur Young Company. He is a cum laude graduate in business administration from the University of Puerto Rico. Mr. Lasanta is a Certified Public Accountant. In 2012, he was awarded the Puerto Rico Manufacturers Association Service Manager of the Year. Mr. Lasanta has served as a Member of the Puerto Rico District Export Council for the U.S. Department of Commerce since January 2014. since 2014.
Age 63
Tenure 10 years
Phone787 278 2709
Webhttps://www.pharmabioserv.com

Pharma-Bio Serv Management Efficiency

The company has return on total asset (ROA) of 0.033 % which means that it generated a profit of $0.033 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0568 %, meaning that it created $0.0568 on every $100 dollars invested by stockholders. Pharma-Bio Serv's management efficiency ratios could be used to measure how well Pharma-Bio Serv manages its routine affairs as well as how well it operates its assets and liabilities.
Pharma Bio Serv currently holds 520.77 K in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. Pharma Bio Serv has a current ratio of 8.89, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Pharma-Bio Serv until it has trouble settling it off, either with new capital or with free cash flow. So, Pharma-Bio Serv's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pharma Bio Serv sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pharma-Bio to invest in growth at high rates of return. When we think about Pharma-Bio Serv's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

CFO Age

Scott CPADiaMedica Therapeutics
59
Adam LevyMineralys Therapeutics, Common
46
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico. Pharma Bio operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 190 people. Pharma Bio Serv [PBSV] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Pharma Bio Serv Leadership Team

Elected by the shareholders, the Pharma-Bio Serv's board of directors comprises two types of representatives: Pharma-Bio Serv inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pharma-Bio. The board's role is to monitor Pharma-Bio Serv's management team and ensure that shareholders' interests are well served. Pharma-Bio Serv's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pharma-Bio Serv's outside directors are responsible for providing unbiased perspectives on the board's policies.
Pedro Lasanta, CFO, VP of Fin. and Admin. and Secretary
Victor Sanchez, CEO and President and President of European Operations
Elizabeth Plaza, Founder, Chairman, Sr. Strategic Consultant and Member of Nominating Committee
Miriam MBA, HR Mang

Pharma-Bio Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Pharma-Bio Serv a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Pharma-Bio OTC Stock Analysis

When running Pharma-Bio Serv's price analysis, check to measure Pharma-Bio Serv's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma-Bio Serv is operating at the current time. Most of Pharma-Bio Serv's value examination focuses on studying past and present price action to predict the probability of Pharma-Bio Serv's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma-Bio Serv's price. Additionally, you may evaluate how the addition of Pharma-Bio Serv to your portfolios can decrease your overall portfolio volatility.